Clinical Trial Update: Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and pharmacology of GDC-0980 in combination with paclitaxel with or without bevacizumab in patients with locally recurrent or me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• GDC-0980
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED